News

According to research, regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with docetaxel.

A team of researchers has shown for the first time that cellular senescence is caused by irreversible damage to the genome rather than simply by telomere erosion.

Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms, feeling thirsty and having dark urine.

A drug called MTI-201, designed to treat uveal melanoma, has been given approval to commence clinical phase testing.

According to research, unraveling the entire genetic code for each child who has been diagnosed with cancer can give a more accurate diagnosis or reveal new treatment options.

In a clinical trial, treatment with arginine enhanced the effectiveness of radiation therapy in cancer patients with brain metastases

Researchers have found that the formation of transcription factories resembles the condensation of liquids. Their findings will improve the understanding of causes of diseases and advance the development of DNA-based data storage systems.

Findings of a study show that an experimental drug enhanced the benefit of immunotherapy to fight pancreatic cancer and in some mice, eliminated the cancer.

Researchers from Rockefeller University have identified a protein called SLC25A39 within the mitochondrial membrane that transports glutathione, the body’s major antioxidant, into the cell’s mitochondria, where free radicals are produced.

Researchers have shown that a prostate cancer urine test can identify men at "intermediate risk" who can safely avoid immediate treatment and benefit from "active surveillance" instead.